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Abstract
Introduction: Perioperative spinal myoclonus is extremely rare. Many anaesthetists and
perioperative practitioners may not diagnose or manage this complication appropriately when it
occurs. This case report of unusual acute spinal myoclonus following regional anaesthesia highlights
certain aspects of this rare complication that have not previously been published.
Case presentations: A series of four consecutive patients who developed acute lower-limb
myoclonus following spinal or epidural anaesthesia are described. The case series occurred at three
different hospitals and involved four anaesthetists over a 3-year period. Two Caucasian men, aged 90-
years-old and 67-years-old, manifested unilateral myoclonus. Two Caucasian women, aged 64-years-
old and 53-years-old, developed bilateral myoclonus. Myoclonus was self-limiting in one patient,
treated with further regional anaesthesia in one patient and treated with intravenous midazolam in
two patients. The overall outcome was good in all patients, with no recurrence or sequelae in any of
the patients.
Conclusion: This case series emphasizes that spinal myoclonus following regional anaesthesia is
rare, has diverse pathophysiology and can have diverse presentations. The treatment of perioperative
spinal myoclonus should be directed at the aetiology. Anaesthetists and perioperative practitioners
who are unfamiliar with this rare complication should be reassured that it may be treated successfully
with midazolam.
Introduction
Spinal myoclonus is a non-generalized neuromuscular
dysfunction that may be focal or segmental, affecting single
muscles or muscle groups [1]. It presents as sudden, shock-
like bursts of involuntary spasms and usually results from
spinal cord pathology such as compression, sepsis, trauma,
degeneration, vasculopathy or neoplasm [1]. It may be
associated with epilepsy, toxicity, drug reactions, intrathecal
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[1,2,3]. Thisreport isa case study anddiscussion of unusual
acute spinal myoclonus following regional anaesthesia.
There are very few published reports on this matter, and
this clinical report highlights certain aspects that have not
been previously discussed in medical literature.
Case presentations
Case 1
A 90-years-old Caucasian man presented for prostatect-
omy. His co-morbidities included atrial fibrillation,
cardiac failure, ischaemic heart disease and hypertension,
but he had no history of neuropathy. Medications
included digoxin, lisinopril, bendrofluazide and nitrates.
Laboratory parameters were normal. He made an
informed choice of regional anaesthesia. Standard perio-
perative monitoring included electrocardiography, non-
invasive blood pressure and pulse oximetry. Combined
spinal/epidural anaesthesia was performed aseptically at
the L3/4 space using a 16 G Tuohy needle and a 26 G
Whitacre needle. Spinal anaesthesia was established with 2
ml of heavy 0.5% bupivacaine and an epidural catheter
inserted for postoperative analgesia. The regional anaes-
thesia procedure was uneventful. Adequate motor and
sensory block was achieved at 10 minutes. Sensory block
to the T8 dermatome was confirmed by loss of cold
sensation. An initial attempt at lithotomy positioning was
associated with right leg myoclonus, which resolved on
placing the patient supine. After 10 minutes, repeat
lithotomy positioning produced similar myoclonus.
Therefore, an epidural dose of 10 ml of 0.25% bupivacaine
was administered, with complete resolution of myoclonus
after another 10 minutes. Surgery and follow-up after
30 days were uneventful.
Case 2
A 64-years-old Caucasian woman presented for uretero-
tomy. Her co-morbidities included bronchitis, coronary
artery disease and diabetes mellitus, but she had no history
of neuropathy. Medications included salbutamol, nitrates
and metformin. The patient made an informed choice of
spinal anaesthesia. Standard perioperative monitoring was
used. Spinal anaesthesia was performed aseptically at the
L3/4 space using a 26 G Whitacre needle and 2 ml of heavy
0.5% bupivacaine. The spinal anaesthesia procedure was
uneventful. Adequate motor and sensory block was
achieved at five minutes. Sensory block up to the T6
dermatome was confirmed by loss of cold sensation. The
intraoperative course was uneventful. After arriving back
on the ward 60 minutes after instituting spinal anaes-
thesia, the patient developed lower-limb myoclonus,
lasting less than three minutes and resolving sponta-
neously. There was no recurrence of myoclonus and no
sequelae. Subsequent spinal block with bupivacaine three
months later was uneventful.
Case 3
A 53-years-old Caucasian woman presented for pelvic
surgery. Her co-morbidities included hypertension and
rheumatoid arthritis but no neuropathy. Medications
included oestradiol, bendrofluazide and dexamethasone.
Previous regional block and general anaesthesia were
uneventful. Serum vitamin B12 level was 191 ng/L
(normal range 200-900 ng/L), but other laboratory
parameters were normal. The patient made an informed
choice of spinal anaesthesia. Standard perioperative
monitoring was used. Spinal block was performed
aseptically at the L3/4 spinal space with a 25 G Whitacre
needle and 2.5 ml of heavy 0.5% bupivacaine plus
diamorphine 300 mcg. The spinal block procedure
was uneventful. Adequate motor and sensory block
was achieved at 5 minutes. Sensory block up to the
T6 dermatome was confirmed by loss of cold sensation.
The intraoperative course was uneventful. However, after
returning to the ward, about 90 minutes after instituting
spinal block, she developed lower-limb myoclonus. The
myoclonus lasted one hour and was treated with
intravenous midazolam 4 mg. Subsequent follow-up for
two weeks revealed no sequelae and no recurrence of
myoclonus.
Case 4
A 67-years-old Caucasian man presented for refashioning
of a left below-knee amputation stump. His co-morbid-
ities included diabetes, cardiovascular disease, peripheral
neuropathy, obesity and asthma. Medications included
insulin, amlodipine, lisinopril, gabapentin and salbuta-
mol. Previous regional block and general anaesthesia were
uneventful. The patient made an informed choice of spinal
anaesthesia. Standard perioperative monitoring was used.
Spinal block was performed aseptically at the L4/5 spinal
space with a 25 G Whitacre needle and 2.5 ml of heavy
0.5% bupivacaine plus diamorphine 300 mcg. The spinal
block procedure was uneventful. Adequate motor and
sensory block was achieved at five minutes. Adequate
sensory block up to the T8 dermatome was confirmed
by loss of cold sensation. The intraoperative course was
uneventful. However, at the end of surgery, about 60
minutes after the spinal blockade, the patient complained
of repetitive muscle spasm in the absent amputated limb.
The phantom spasm was distressful to the patient and was
promptly treated withintravenous midazolam 5 mg.There
was no recurrence of myoclonus and no sequelae.
Discussion
Spinal myoclonus is rare and usually involves muscles
innervated by adjacent spinal-cord segments [1]. The
pathophysiology of spinal myoclonus includes abnormal
loss of inhibition from suprasegmental descending path-
ways, loss of inhibition from local dorsal horn interneur-
ons, hyperactivity of contiguous anterior horn neurons,
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or suprasegmental inhibitory function in the spinal cord
may account for the myoclonus in this report. Myoclonus
following regional anaesthesia is extremely rare, and there
are only very few reports [3,4]. This case series occurred at
three different hospitals and involved four anaesthetists
over a three-year period. Rapid onset of myoclonus less
than 90 minutes after spinal anaesthesia, as in our report,
is extremely unusual. Previous reports recorded later onset
times of many hours or days [3,4]. There is no obvious
explanation for the extremely acute onset of myoclonus in
our patients. The pathophysiology may be related to the
neurotoxic effect of local anaesthetics or opioids and local
neuronal irritation by spinal needle or catheter.
Spinal myoclonus may result from high-dose spinal,
epidural or systemic opioid therapy [2,5,6]. High doses
of spinal opioid combined with spinal-cord or nerve
degeneration are risk factors [5]. Intravertebral disease is
associated with increased risk of myoclonus because of the
combination of spinal-cord/nerve dysfunction and high
intrathecal or systemic opioid analgesia requirement. The
pathophysiology of myoclonus following high-dose
opioid analgesia may involve an imbalance between the
activity of spinal and central opioid receptors or direct
opioid toxicity on the medulla spinalis [5].
The management of opioid-induced spinal myoclonus
involves change of opioid, dose reduction or change from
intrathecal to systemic administration. Intrathecal dose
reduction may be combined with systemic administration
to improve the imbalance between spinal and central
opioid receptor activity [5]. None of the patients in this
report received high doses of intrathecal opioid, and the
two patients who did receive intrathecal opioid were
administered a low dose of diamorphine 300 mcg.
Therefore, these cases of spinal myoclonus are unlikely
to be opioid-induced. However, it is possible that low
doses of intrathecal opioid may contribute to spinal
myoclonus in the presence of spinal-cord or neuromus-
cular dysfunction.
Local anaesthetic neurotoxicity may cause spinal myoclo-
nus, and there have been some debate and reports
regarding this adverse effect [3,4,7]. However, bupivacaine
was the local anaesthetic administered to the patients in
this report, and it has a good safety record especially at low
doses of less than 13 mg, such as administered to these
patients [7]. Although unlikely, it is possible that the
occurrence of myoclonus was associated with local
anaesthetic neurotoxicity in the presence of subtle under-
lying neuropathy.
Spinal myoclonus may result from local neuronal irrita-
tion or injury by the intrathecal needle or catheter. Spinal-
cord or nerve injury presents with pain during the regional
anaesthesia procedure and subsequent acute neuropathy,
with or without myoclonus, which may be unilateral or
bilateral [1,3,8]. Indwelling spinal or epidural catheters
may cause myoclonus by irritating the spinal cord or nerve
roots, and this complication can be treated by with-
drawing the offending catheter [9]. Procedural neurologic
injury may precipitate spinal myoclonus by causing
abnormal impulse transmission or aberrant hyper-
excitability in the spinal nerve root, with consequent
disturbance of spinal inhibitory neurons and hyper-
excitability of anterior horn cells. Sympathetic hyper-
excitability may also contribute to spinal myoclonus [1,8].
There was no obvious neurologic trauma during the
regional block procedure for our patients, because
the procedure was uneventful and comfortable for all the
patients. However, subtle neurologic irritation may not
manifest significant pain, but may aggravate pre-existing
neuropathy and result in perioperative myoclonus such as
in Case 4. Three patients denied pre-existing neuropathy,
b u ti ti sp o s s i b l et h a tt h e yh a ds o m ed e g r e eo f
undiagnosed subtle pre-existing neuropathy, especially
Patient 1 who was 90-years-old with risk of neuro-
degeneration and Patient 2 who had diabetes with risk
of neuropathy.
Unilateral spinal myoclonus following regional anaesthe-
sia, such as in Case 1 and Case 4, is extremely rare. A
previous report involved epidural needle injury followed
by rapid-onset spinal myoclonus, which was relieved by
lumbar plexus block [8]. The patient in Case 1 developed
unilateral myoclonus following spinal block, which was
relieved by further regional anaesthesia in the form of
epidural block. Although it may seem somewhat ironic,
the administration of further regional anaesthesia is an
effective means of treating myoclonus following regional
block, possibly by correcting the disinhibition and
hyperactivity in the spinal cord [6,8]. Another report of
unilateral myoclonus involved intrathecal catheter irrita-
tion of spinal nerve root, with occurrence of spinal
myoclonus whenever the patient stood up from a seated
position; this was treated by catheter withdrawal [9]. The
myoclonus in Patient 1 occurred at initial attempts to
place the patient in lithotomy position. This may be
associated with neuronal irritation by the indwelling
epidural catheter and/or stretching of the spinal nerves
during hip flexion. There is a report of amputation-stump
myoclonus [10], but our report of phantom-limb spasm in
Patient 4 is unique and not previously reported. We
believe this phantom spasm was due to loss of inhibition
from descending spinal-cord pathways.
Vitamin deficiency syndromes may predispose to neuro-
pathy and perianaesthesia myoclonus [11,12]. A possible
contributory factor to the myoclonus in Patient 3 is the
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associated with myelopathy and neuropathy [11]. How-
ever, the degree of deficiency in our patient was mild and
she did not require vitamin B12 therapy for the resolution
of myoclonus. Lower-limb neuropathy after spinal block
has been reported in a case of thiamine deficiency [12].
Chronic use of certain medications may predispose to
spinal myoclonus. The patients in Case 1 and Case 3 were
on chronic diuretic therapy, with the risk of electrolyte
disorder which may predispose to neurologic dysfunction.
However, none of the patients had electrolyte derange-
ments. The patient in Case 3 was on chronic dexametha-
sone and oestradiol therapy, and chronic steroid therapy is
associated with neuropathy [13]. Although difficult to
prove, this may be a contributory factor to the spinal
myoclonus in Patient 3.
The treatment of spinal myoclonus involves detection of
the aetiology, abolition or minimisation of the aetiology,
and symptomatic treatment with benzodiazepines, baclo-
fen, anticonvulsants or serotoninergics [1,14]. If treatment
of the underlying disorder is impossible, symptomatic
treatment is worthwhile, although limited by side-effects
and lack of controlled evidence. Intrathecal baclofen is
effective therapy for spinal myoclonus [1] but was not
attractive to our team and patients because of the route of
administration and adverse central neurologic effects.
Anticonvulsants such as carbamazepine, topiramate and
sodium valproate are also effective [10,14].
Benzodiazepines are effective anticonvulsants and should
constitute the mainstay of treatment for myoclonus [14].
Diazepam and clonazepam have been used successfully.
Midazolam was used for treatment in two of our patients
because it is readily available in ready-to-use, injectable
form. It is highly potent,painless oninjection, rapid-onset,
with predictable effect and duration [14]. Thus, we believe
that midazolam is the benzodiazepine of choice for
treating perioperative spinal myoclonus. It is also arguable
that the low incidence of perioperative myoclonus
may be related to the relative use of midazolam for
premedication.
Conclusion
Acute spinal myoclonus following regional anaesthesia is
extremely rare, and treatment should be directed at the
aetiology. Anaesthetists should watch out for this anaes-
thetic complication, especially in patients with underlying
vitamin deficiency or neuromuscular disease. Anaesthe-
tists who are unfamiliar with this rare complication should
be reassured that it may be treated successfully with
midazolam. Extra caution should be taken when admin-
istering intrathecal opioid or anaesthetic in patients
with known or suspected neuromuscular dysfunction.
Long-term follow-up is vital to monitor for recurrence or
sequelae.
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